Affordable GLP-1 Weight Loss Injections in Philadelphia and NYC
Explore affordable, physician-supervised semaglutide- and tirzepatide-based weight-management options through W8MD's active offices in Northeast Philadelphia and Brooklyn, New York City.
W8MD GLP-1 starting prices
W8MD offers different payment pathways based on whether a qualifying medical visit can be billed to insurance. The advertised amounts below are starting prices, not guaranteed prices for every dose or patient.
When insurance is accepted for qualifying medical visits.
From $59.99/week+Self-pay starting option.
When insurance is accepted for qualifying medical visits.
From $69.99/week+Self-pay starting option.
Pricing qualification: Medical evaluation is required. Eligibility, medication source, dose, supply, visit frequency, pharmacy, insurance participation, deductibles, copayments and total cost vary. Insurance payment for a visit does not mean the health plan covers the medication. Ask W8MD exactly what the quoted price includes. Offers may change without notice.
Semaglutide and tirzepatide are not the same treatment
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Drug action | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| FDA-approved weight-management brand | Wegovy | Zepbound |
| Diabetes brand containing the ingredient | Ozempic | Mounjaro |
| Typical administration | Product-specific weekly injection; an oral Wegovy formulation also has its own label | Product-specific weekly injection |
| Selection | Based on approved indication, medical history, contraindications, expected benefit, side effects, availability, coverage, budget and patient preference. | |
Who may be considered for prescription weight management?
FDA-approved chronic weight-management medicines generally have product-specific eligibility requirements. For many adult products, the labeled population includes adults with obesity or adults with overweight plus at least one weight-related condition, alongside reduced-calorie nutrition and increased physical activity. The exact indication and thresholds must be checked in the current prescribing information.
Weight-related health review
The clinician may review blood pressure, cholesterol, prediabetes or diabetes, fatty liver disease, sleep apnea, mobility, PCOS and other relevant conditions.
Contraindication review
History may include pregnancy plans; gastrointestinal, gallbladder, pancreatic, kidney and endocrine concerns; current medications; and product-specific warnings.
Long-term planning
Good care considers nutrition, protein, fluids, physical activity, muscle preservation, side-effect management, plateaus and maintenance—not merely the first injection.
What physician-supervised GLP-1 care at W8MD may include
1. Medical evaluation
- Weight and treatment history
- Medication and contraindication review
- Cardiometabolic and sleep-apnea risk
- Individual goals and treatment preferences
2. Personalized treatment selection
When appropriate, the clinician may discuss an FDA-approved GLP-1 or GIP/GLP-1 product, another prescription weight-loss medication, structured nutrition, meal replacements or a non-medication pathway.
3. Nutrition and muscle preservation
Reduced appetite can make it harder to consume adequate protein and nutrients. W8MD can help patients build a practical eating plan and discuss resistance activity when appropriate.
4. Follow-up and maintenance
Follow-up may address tolerability, dose decisions, constipation or nausea, hydration, progress, medication access and a sustainable plan if treatment or insurance changes.
How insurance and prior authorization work
There are two separate questions: whether an insurance plan covers the medical visit and whether its pharmacy benefit covers the prescribed medication. Coverage varies by plan—not simply by insurance-company name.
- W8MD confirms current visit participation and benefits when possible.
- The clinician determines whether prescription treatment is medically appropriate.
- If the plan covers the requested medication and prior authorization is required, relevant clinical documentation may be submitted.
- The insurer or pharmacy-benefit manager—not W8MD—makes the approval decision.
- Patients should confirm deductibles, copays, coinsurance, quantity limits, step therapy, renewal rules and pharmacy network.
W8MD patient experiences
“Fantastic program! Truly a life changer. I lost 87 pounds in 10 months.”
— D.M., W8MD patient story
Reported experience; individual results vary.Education patients can use
Another W8MD patient, Donna, described appreciating the physician's explanations about nutrition and how food choices affect weight. Her feedback highlights the value of understanding the plan rather than receiving medication without education.
Testimonials describe individual experiences and do not guarantee a particular amount or rate of weight loss. Results depend on health, treatment, nutrition, physical activity, sleep, adherence, duration and follow-up.
W8MD offices serving Philadelphia and New York City
Northeast Philadelphia
W8MD Weight Loss, Sleep & MedSpa
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115
Serving Northeast Philadelphia, Greater Philadelphia, Bucks County, South Jersey, Delaware and surrounding communities.
Philadelphia medical weight-loss informationBrooklyn / New York City
W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235
Serving Brooklyn, Queens, Manhattan, Staten Island, the Bronx, Long Island and nearby communities.
NYC medical weight-loss and GLP-1 clinic informationW8MD does not claim offices in every listed service area. Patients are served through the active Brooklyn and Northeast Philadelphia locations. Telehealth follow-up may be available when clinically appropriate and legally permitted.
Explore the W8MD health network
Frequently asked questions
Does semaglutide really start at $29.99 per week?
W8MD advertises semaglutide-based options starting from $29.99 per week and up when insurance is accepted for qualifying visits. The starting self-pay option is $59.99 per week and up. Evaluation, dose, source, pharmacy, insurance and total cost vary.
Does tirzepatide really start at $45 per week?
W8MD advertises tirzepatide-based options starting from $45 per week and up when insurance is accepted for qualifying visits. The starting self-pay option is $69.99 per week and up. The price is not guaranteed for every patient or dose.
Does the advertised price mean I receive Wegovy or Zepbound?
Not necessarily. Ask the office to identify the exact product, dose, manufacturer or dispensing pharmacy and whether it is FDA approved. A compounded product is not FDA-approved Wegovy or Zepbound and is not a generic equivalent.
Will insurance pay for my medication?
Possibly, but coverage depends on the exact plan, diagnosis, formulary and prior-authorization rules. Insurance coverage of a W8MD visit does not guarantee medication coverage.
Is everyone eligible for a GLP-1 prescription?
No. Eligibility depends on the product's indication, BMI or weight-related conditions, health history, contraindications, pregnancy considerations, current medications and clinician judgment.
What side effects can occur?
Common effects may include nausea, vomiting, diarrhea, constipation and abdominal symptoms. Product labels also contain important contraindications and warnings. Patients should receive individualized guidance about when symptoms require prompt or emergency care.
Can W8MD help with weight maintenance?
Yes. W8MD's approach can include nutrition, medication review, sleep evaluation, physical-activity planning and follow-up focused on maintaining progress. No result is guaranteed.
How do I get started?
Call the Northeast Philadelphia office at 215-676-2334 or the Brooklyn/NYC office at 718-946-5500 to ask about evaluation, current availability, insurance and self-pay options.
Ask W8MD which weight-management pathway fits you
Speak with the appropriate office about physician-supervised options, current pricing, insurance benefits and appointment availability.
